Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Shanti, Eswaran"'
Autor:
Eric D. Shah, Jessica K. Salwen-Deremer, Peter R. Gibson, Jane G. Muir, Shanti Eswaran, William D. Chey
Publikováno v:
MDM Policy & Practice, Vol 6 (2021)
Introduction. Irritable bowel syndrome (IBS) is the most common gastroenterology referral and one of the most common gastrointestinal complaints in primary care. We performed a cost-utility analysis of the most common treatments available in general
Externí odkaz:
https://doaj.org/article/19ce2652df2248529a024af096a5cf59
Publikováno v:
Current Treatment Options in Gastroenterology. 19:500-508
Our review focuses on the various presentations, diagnosis, and treatment of sucrose–isomaltase deficiency (SID), previously thought to be limited to the pediatric population with severe malabsorptive symptoms. Although sucrase–isomaltase deficie
Autor:
Allen Lee, Krishna Rao, Emily Haller, Lauren Van Dam, Jason Baker, Shanti Eswaran, William Chey, Vincent Young, Chung Owyang, William Hasler
Publikováno v:
Journal of Clinical and Translational Science, Vol 3, Pp 31-31 (2019)
OBJECTIVES/SPECIFIC AIMS: Objectives and goals of this study are to (i) determine whether IBS-D patients randomized to either rifaximin or low FODMAP diet show improvement in IBS-related symptoms; and (2) identify using longitudinal analyses how SIBO
Externí odkaz:
https://doaj.org/article/cb2568cbd8d74253a2844e26a7402447
Publikováno v:
Techniques and Innovations in Gastrointestinal Endoscopy. 23:249-255
Healthcare organizations have recognized the value of physician leaders in change management and achieving institutional goals. Physicians leaders are now at all levels from individual clinics to the very top of large, multi-hospital organizations. M
Autor:
Jessica K. Salwen-Deremer, Laurie Keefer, Lin Chang, Shanti Eswaran, Eric D. Shah, Jane G. Muir, Peter R. Gibson, William D. Chey
Publikováno v:
American Journal of Gastroenterology. 116:748-757
Introduction Insurance coverage is an important determinant of treatment choice in irritable bowel syndrome (IBS), often taking precedence over desired mechanisms of action or patient goals/values. We aimed to determine whether routine and algorithmi
Publikováno v:
The American journal of gastroenterology. 117(6)
The aim of this study was to identify benefits and barriers to using a gastroenterology (GI) dietitian for irritable bowel syndrome (IBS) care.A 25-question survey was electronically distributed to the members of the American College of Gastroenterol
Autor:
Peter R. Gibson, William D. Chey, Jane G. Muir, Eric D. Shah, Jessica K. Salwen-Deremer, Shanti Eswaran
Publikováno v:
MDM Policy & Practice
MDM Policy & Practice, Vol 6 (2021)
MDM Policy & Practice, Vol 6 (2021)
Introduction. Irritable bowel syndrome (IBS) is the most common gastroenterology referral and one of the most common gastrointestinal complaints in primary care. We performed a cost-utility analysis of the most common treatments available in general
Publikováno v:
The American journal of gastroenterology. 116(6)
INTRODUCTION Psyllium and prunes are proven treatments for chronic constipation (CC). Asian studies suggest that kiwifruit may also benefit CC symptoms. We report a partially randomized, comparative effectiveness trial evaluating kiwifruit, psyllium,
Publikováno v:
Annual review of medicine. 71
Irritable bowel syndrome (IBS) is the most prevalent of gastrointestinal (GI) conditions, affecting millions of people worldwide. Given that most IBS patients associate their GI symptoms with eating food, specific dietary manipulation has become an a
Autor:
Stacy B, Menees, Kenya, Jackson, Jason R, Baker, Dee E, Fenner, Shanti, Eswaran, Borko, Nojkov, Richard, Saad, Allen A, Lee, William D, Chey
Publikováno v:
Clinical and Translational Gastroenterology. 13:e00454
The aim of the study was to compare the effectiveness of a low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet (LFD) vs psyllium on the frequency and severity of fecal incontinence (FI) episodes in patients with loose stool